Kolbot By

Directeur Technique/Scientifique/R&D chez ALUMIS INC.

Health Technology

Consumer Services

Profil

Kolbot By currently works at Alumis, Inc., as Senior Vice President & Head-Technical Operations from 2022.
Dr. By also formerly worked at Rain Oncology, Inc., as Senior Vice President-Technical Operations from 2021 to 2022 and Principia Biopharma, Inc., as Vice President-Chemical Development.
Dr. By received his doctorate degree from the University of California, Davis and undergraduate degree from the University of California, Santa Barbara.

Postes actifs de Kolbot By

Sociétés	Poste	Début
ALUMIS INC.	Directeur Technique/Scientifique/R&D	01/01/2022

Tous les postes actifs de Kolbot By

Anciens postes connus de Kolbot By

Sociétés	Poste	Fin
RAIN ONCOLOGY INC.	Directeur Technique/Scientifique/R&D	01/01/2022
PRINCIPIA BIOPHARMA INC.	Corporate Officer/Principal	-

Voir l'expérience en détail de Kolbot By

Formation de Kolbot By

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Kolbot By

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	5
Principia Biopharma, Inc. Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company	Health Technology
University of California, Davis University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of California, Santa Barbara University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Rain Oncology, Inc. Rain Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage precision oncology company that develops therapeutics for cancer patients	Health Technology
Alumis, Inc. Alumis, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of medicines for autoimmune disorders	Health Technology